Dihydroergotamine Mesylate and Insulin degludec Subcutaneous
Determining the interaction of Dihydroergotamine Mesylate and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Insulin detemir
- Dihydroergotamine Mesylate-Insulin Detemir (Cartridges and Prefilled Syringes)
- Dihydroergotamine Mesylate-Insulin Detemir (Vials)
- Dihydroergotamine Mesylate-Insulin detemir Subcutaneous
- Dihydroergotamine Mesylate-Insulin glargine
- Dihydroergotamine Mesylate-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Dihydroergotamine nasal
- Insulin degludec Subcutaneous-Dihydroergotamine Nasal Spray
- Insulin degludec Subcutaneous-Dilacor XR
- Insulin degludec Subcutaneous-Dilantin
- Insulin degludec Subcutaneous-Dilantin Infatabs
- Insulin degludec Subcutaneous-Dilantin injection